August 2, 2016 / 10:02 PM / a year ago

BRIEF-SIFI s.p.a., Knight Therapeutics in canadian license agreement for NETILDEX(tm)

1 Min Read

Aug 2 (Reuters) - Knight Therapeutics Inc

* SIFI s.p.a. and Knight Therapeutics announce canadian license agreement for NETILDEX(tm)

* Knight will also handle all ongoing regulatory and commercial activities for netildex(tm) in canada. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below